Updates & Interim Data of mRNA-Based Cancer Vaccines to Treat EBV-Related Cancers
Time: 9:00 am
day: Day One AM
Details:
- Present breakthroughs in the treatment of EBV-related cancers, including NPC and NKT lymphoma
- Highlight safety and efficacy based on ongoing enrollment and interim data
- Demonstrate the transformative potential of mRNA therapeutics in the treatment of viral-related malignancies
